Anesthesia & Analgesia
July 2002
Table of Content
¦ñ©M¤£¦ñ¦³³N«á»{ª¾»ÙꪺCABG³N¯f¤H¤¤ªº¦å²M¦ÙÓþÅܤÆ
¡]©P¼ä
Ķ
¤ý²»·ç®Õ¡^
Serum Creatinine Patterns in Coronary Bypass Surgery Patients With and
Without Postoperative Cognitive Dysfunction
Madhav Swaminathan, Brian J. McCreath, Barbara G. Phillips-Bute, Mark F. Newman,
Joseph P.
Departments of *Anesthesiology, Surgery (Cardiothoracic
Division), and Medicine and Psychiatry,
Anesth & Analg July 2002 95:1-8.
¡@
¤ß¦Ù¯Ê¦å©M²ÓM¦]¤l»P«D¤ßŦ¤â³N«áªº·P¬V¬ÛÃö
¡]©P¼ä
Ķ
¤ý²»·ç®Õ¡^
Myocardial Ischemia and Cytokine Response Are Associated with Subsequent Onset of Infections After Noncardiac Surgery
laudia D. Spies, MD*, Hartmut Kern, MD*, Torsten Schröder, MD*, Michael Sander, MD*, Henning Sepold, MD*, Philip Lang, MD*, Karl Stangl, MD, Steffen Behrens, MD, Pranav Sinha, MD, Walter Schaffartzik, MD||, Klaus-Dieter Wernecke, PhD¶, Wolfgang J. Kox, MD, PhD*, and Uday Jain, MSIT, PhD, MD#
Departments of *Anesthesiology and Intensive Care Medicine and Cardiology and Institute of Clinical Chemistry and Pathological Biochemistry, University Hospital
Anesth & Analg July 2002 95:9-18.
¤C¬tîŹﰷ±d©M¤ß¦Ù¯fܹ«¥æ´À©Ê¥¿©Ê¦Ù¤O§@¥Î
¡]¤ý¤h¹pĶ Éܤߨ}®Õ¡^
The Paradoxical Positive Inotropic Effect of Sevoflurane in Healthy and Cardiomyopathic Hamsters
Benoît Vivien, MD*, Jean-Stéphane David, MD, Jean-Luc Hanouz, MD, PhD, Julien Amour, MD*, Yves Lecarpentier, MD, PhD, Pierre Coriat, MD*, and Bruno Riou, MD, PhD*||
*Laboratory of Experimental Anesthesiology, Department of Anesthesiology, Centre Hospitalier Universitaire (CHU) Pitié-Salpêtrière, Université Paris VI, Paris, France; Department of Anesthesiology, CHU Edouard Herriot, Lyon, France; Department of Anesthesiology, CHU Côte de Nacre, Caen, France; Department of Physiology, CHU de Bicêtre, and Institut National de la Santé et de la Recherche Médicale, Palaiseau, France; and ||Department of Emergency Medicine, CHU Pitié-Salpêtrière, Université Paris VI, Paris, France
Anesth & Analg July 2002 95:31-38
¡@
Rapacuronium¹ï³Â¾K¤Iµ£ªÍÉó±ñªº¼vÅT¡GÉO¬üºûªQ¤ñ¸û
¡]»¯³·½¬Ä¶ Éܤߨ}®Õ¡^
The Effect on Lung Mechanics in Anesthetized Children with Rapacuronium: A Comparative Study with Mivacurium
Gavin
F. Fine, MB, BCh*
, Etsuro K. Motoyama, MD*![]()
![]()
, Barbara W. Brandom, MD*
, Kathleen M. Fertal, BSN*, Rebecca Mutich, RRT
, and Peter J. Davis, MD*![]()
![]()
*Department of Anesthesiology and
Division of Pulmonology, Children¡¦s
Hospital of Pittsburgh; and the Departments of
Anesthesiology and
Pediatrics, University of
Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
Anesth & Analg July 2002 95:56-61
¡@
¥iÅs¦±¤ä®ðºÞÃè¼ÒÀÀ¾¹®ð¹D¼ÒÀÀ¾¹ªºªºµû¦ô
¡]©P¼ä
Ķ
¤ý²»·ç®Õ¡^
An Evaluation of a Virtual Reality Airway Simulator
Richard Rowe, MD, MPH*, and Ronald A. Cohen, MD
Departments of *Anesthesiology and Diagnostic Imaging, Children¡¦s Hospital Oakland, Oakland; and Departments of Anesthesiology and Radiology, University of California, San Francisco School of Medicine, San Francisco, California
Anesth & Analg July 2002 95:62-66.
¡@
¡]¤ý¤h¹pĶ Éܤߨ}®Õ¡^
Awareness and Recall in Outpatient Anesthesia
Johanna
Wennervirta, MD*, Seppo O.-V. Ranta, MD*, and Markku Hynynen,
MD, PhD![]()
*Department of Anesthesia and Intensive Care Medicine, Helsinki University
Central Hospital, Children¡¦s Hospital, Helsinki, Finland; and
Department of Anesthesia
and Intensive Care, Helsinki University Central Hospital, Jorvi Hospital, Espoo,
Finland
Anesth & Analg July 2002 95:72-77
¡@
£\-7·ÏÆP«¬¤AýHÁxÆP¨üÅé¹ïÉݬtîŪº±Ó·P©Ê¦³¿à¨üÅ饢¬¡ºA
¡]·¨«O¥òĶ Éܤߨ}®Õ¡^
Sensitivity of the £\-7 Nicotinic Acetylcholine Receptor to Isoflurane May Depend on Receptor Inactivation
Pamela Flood, MD, FACA, and Kristen M. Coates, BS
Department of Anesthesiology, Columbia University, New York
Anesth & Analg July 2002 95:83-87
¡@
¤p¾¯¶q´âÓiଥi§ïµ½³N«á¯f¤H§íÆ{ª¬ºA
¡]Êã¬öµØÄ¶
¤ý²»·ç®Õ¡^
Small-Dose
Ketamine Improves the Postoperative State of Depressed Patients
Akira Kudoh, MD*,Yoko Takahira, Hiroshi Katagai, MD, Tomoko Takazawa, MD
*Department of Anesthesiology, Hakodate Watanabe Hospital; and department of Anesthesiology, Hirosaki National Hospital, Hirosaki, Aomori, Japan
Anesth & Analg July 2002 95:114-118.
¡@
µ[¬ÄÁxÆP¯à¦w¥þ¥Î¤_°ª¹[¦å¯gªº¯f¤H¶Ü¡S
(ÃCÀÜĶ ²ø¤ß¨}®Õ)
Can Succinylcholine Be Used Safely in Hyperkalemic Patients?
Adam
J. Schow, MD*, David A. Lubarsky, MD, MBA
, Ronald P. Olson, MD*, and Tong J. Gan, MB*
*Department of Anesthesiology, Duke University Medical Center, Durham, North
Carolina; and
Department of Anesthesiology, University of Miami/Jackson
Medical Center, Florida Anesth & Analg July 2002 95:119-122
¹ï°ü¬ì³N«e©M³N«á¯kµhµû¦ôªº¤@ºØ¦³®Ä¥i¾aªº·s¤èªk
¡]Êã¬öµØ Ķ
¤ý²»·ç®Õ¡^
A New Highly Reliable Instrument for the Assessment of
Pre- and Postoperative Gynecological Pain
Elisabet
Stener-Victorin,RPT,PhD*, Jan Kowalski, BS, and Thomas Lundeberg,MD,PhD
·ç¨åºq¼w³ù¤j¾Ç°ü²£¬ì¾Ç¨t¡Q´µ¼wôº¸¼¯Karolinska¾Ç·|¥Í²z¾Ç©MÃIJz¾Ç¤À·|¡Q·ç¨å´µ¼wôº¸¼¯KarolinskaÂå°|Ãľ¯
Anesth & Analg July 20002
95:151-157.
¡@
¸¡¦¡¥þ¤l®c¤Á°£³N«á¤_¸¡½¤¤º©M¤Á¤fÀ³¥Î¥¬¤ñ¥d¦]¥[µÇ¤W¸¢¯ÀªºÂíµh®ÄÀ³
¡]»ôªi
Ķ
¤ý²»·ç®Õ¡^
The Analgesic Effects of Intraperitoneal and Incisional Bupivacaine with Epinephrine After Total Abdominal Hysterectomy
A.Ng, FRCA*, A. Swami, FFARCSI*, G. Smith, MD, FRCA*, A.C. Davidson, FRCOG, and J. Emembolu, FRCOG
*University Department of Anaesthesia, Critical Care, and Pain Management, and Department of Obstetrics and Gynaecology, Leicester Royal Infirmary, Leicester LE1 5WW, United Kingdom
Anesth & Analg July 2002 95:158-162
¡@
³æ·¥©MÂù·¥ÉaºÞ¤º¹q·¥¥Î¤_¹q¨ë¿E³qÉa
¡]¸¯Éoª÷Ķ Éܤߨ}®Õ¡^
Electroventilation with Monopolar and Bipolar Intratracheal Electrodes
Zachary W. Sopcak, MSBME, L. A. Geddes, PhD, Kirk S. Foster, BSEE, William E. Schoenlein, BS, and Joe D. Bourland, PhD
Purdue University Department of Biomedical Engineering, West Lafayette, Indiana
Anesth & Analg July 2002 95:189-191
¡@
«Ø¥ßÀ£¤O-±±¨î¼Ò¦¡®ÉÉaºÞ¾ÉºÞ³vº¥ªý¶ë®É¼éÉa¶qÅܤƪº¼Ò«¬
¡]»¯³·½¬Ä¶ Éܤߨ}®Õ¡^
Modeling the Effect of Progressive Endotracheal Tube Occlusion on Tidal Volume in Pressure-Control Mode
Avery
Tung, MD*, and Sherwin E. Morgan, RRT![]()
Departments of
*Anesthesia and Critical Care and
Respiratory Therapy, University of Chicago, Chicago,
Illinois
Anesth & Analg July 2002 95:192-197
µw½¤¥~À³¥Î¥¬¤ñ¥d¦]©Mùûê¥d¦]¤À®YÂíµhªº¬Û¹ï¹B°Ê¯«¸gªýº¢®Ä¯à
¡]»ôªi
Ķ
¤ý²»·ç®Õ¡^
The Relative Motor Blocking Potencies of Epidural Bupivacaine and Ropivacaine in Labor
Héctor J. Lacassie, MD*, Malachy O. Columb, FRCA, Héctor P. Lacassie, MD, and Rodrigo A. Lantadilla, MD*
*Anesthesiology Department, Pontificia Universidad Católica de Chile; and Anesthesiology Service, Clínica Alemana, Santiago, Chile; and South Manchester University Hospital, Withington, United Kingdom
Anesth & Analg July 2002 95:204-208.
¡@
§¤°©¯«¸gªýº¢«e¸ôªkªº·s¼Ð§Ó¡G¼v¹³¾Ç©MÁ{§É¬ã¨s
¡]µJ§ÓµØÄ¶ Éܤߨ}®Õ¡^
New Landmarks for the Anterior Approach to the Sciatic Nerve Block: Imaging and Clinical Study
Alain C. Van Elstraete, MD*, Claude Poey, MD, Thierry Lebrun, MD*, and Frédéric Pastureau, MD*
Departments of *Anesthesiology and Radiology, Saint-Paul Medical Center, Fort de France, Martinique, France
Anesth & Analg July 2002 95:214-218
°§C§l¤J¯º®ð¿@«×«á¹ïÂùµÄºÞ¤ä®ðºÞ®MÅn¨³³t©ñ®ðªº¬ã¨s
¡]Êã¬öµØ
Ķ
¤ý²»·ç®Õ¡^
Rapid Deflation of the Bronchial Cuff of the Double-Lumen Tube After Decreasing the Concentration of Inspired Nitrous Oxide
Fujio Karasawa, MD, Akira Takita, MD, Isao Takamatsu, MD, Tomohisa Mori, MD, Takashi Oshima, MD, and Yasushi Kawatani, MD
Department of Anesthesiology, National Defense Medical College, Saitama, Japan
Anesth & Analg July 2002 95:238-242.
¡@
N2O³Â¾K®É®ðºÞ®MÅn«½Æ©ñ®ð¥Héw®MÅn¤ºÀ£¤O
¡]µJ§ÓµØÄ¶ ²ø¤ß¨}®Õ¡^
Repeated Deflation of a Gas-Barrier Cuff to Stabilize Cuff Pressure During Nitrous Oxide Anesthesia
Fujio Karasawa, MD, Nobuhiro Matsuoka, MD, Mitsuyoshi Kodama, MD, Tomohiro Okuda, MD, Tomohisa Mori, MD, and Yasushi Kawatani, MD
Department of Anesthesiology, National Defense Medical College, Tokorozawa, Saitama, Japan
Anesth & Analg July 2002 95:243-248
Abstracts
¡@
¦ñ©M¤£¦ñ¦³³N«á»{ª¾»ÙꪺCABG³N¯f¤H¤¤ªº¦å²M¦ÙÓþÅܤÆ
Serum Creatinine Patterns in Coronary Bypass Surgery Patients With and Without Postoperative Cognitive Dysfunction
Madhav Swaminathan, Brian J. McCreath, Barbara G. Phillips-Bute, Mark F. Newman, Joseph P.
Departments of *Anesthesiology, Surgery (Cardiothoracic
Division), and Medicine and Psychiatry,
Anesth & Analg July 2002 95:1-8.
¥Øªº CABG³N«áµÇ¥\¯à»Ùê¸û¬°±`¨£¡C§Ú̦´Nµo²{CABG³N¤¤¦ñ¦³¸£¨ò¤¤ªº¯f¤H¨ä¦å²M¦ÙÓþ¬°¥¼¦ñ¦³¸£¨ò¤¤ªÌªº¤T¿¡C¦ý¬O¡M³N«á¦ÙÓþÅܤƬO§_¦X¨Ö»{ª¾»ÙêÁÙ¥¼±oª¾¡C¦]¦¹¡M§Ṵ́²³]CABG³N«áªº³ò³N´Á«æ©ÊµÇ¥\¯à·l¶Ë»P³N«á»{ª¾»Ù꦳Ãö¡C¤èªk ¿ï¾Ü282¨Ò¾Ü´ÁCABG³N¯f¤H,¤_³N«e©M³N«á6©P¶i¦æ¤ß²z´ú¶q¸ÕÅç¨Ã¦æ¸ê®Æ²Îp¡C»{ª¾¥\¯à»Ùê©w¸q¬°¨ü¨â¤ÀÅܶq¡]»{ª¾¯Ê³´[CD]¡^©M³sÄòÅܶq¡]»{ª¾«ü¼Æ¡^¡Cµ²ªG 40%ªº¯f¤H¦b³N«á6©P¦³CD¡C¦ý¬O¡M¹ï³N«á¦ÙÓþ©MCD¡]¬ÛÃö©Ê=-0.41¡QP=0.91¡^©Î»{ª¾«ü¼Æ¡]¬ÛÃö©Ê=-1.29¡QP=0.46¡^¤§¶¡ªº¦Ê¤À¤ñ®pÅܤƪº¬ÛÃö¬ã¨sªí©ú¡R¨âªÌµL©úÅã¬ÛÃö¡Cµ²½× ¤ßŦ³N«áªº»{ª¾»Ùê»P¸£¨ò¤¤¤£¦P¡M»P³N«áµÇ¥\¯à»Ùꪺ¼W¥[µLÃö¡C
¡]©P¼ä Ķ ¤ý²»·ç®Õ¡^
Renal dysfunction is common after coronary artery bypass graft (CABG) surgery. We have previously shown that CABG procedures complicated by stroke have a threefold greater peak serum creatinine level relative to uncomplicated surgery. However, postoperative creatinine patterns for procedures complicated by cognitive dysfunction are unknown. Therefore, we tested the hypothesis that postoperative cognitive dysfunction is associated with acute perioperative renal injury after CABG surgery. Data were prospectively gathered for 282 elective CABG surgery patients. Psychometric tests were performed at baseline and 6 wk after surgery. Cognitive dysfunction was defined both as a dichotomous variable (cognitive deficit [CD]) and as a continuous variable (cognitive index). Forty percent of patients had CD at 6 wk. However, the association between peak percentage change in postoperative creatinine and CD (parameter estimate = -0.41; P = 0.91) or cognitive index (parameter estimate = -1.29; P = 0.46) was not significant. These data indicate that postcardiac surgery cognitive dysfunction, unlike stroke, is not associated with major increases in postoperative renal dysfunction.
¤ß¦Ù¯Ê¦å©M²ÓM¦]¤l»P«D¤ßŦ¤â³N«áªº·P¬V¬ÛÃö
Myocardial Ischemia and Cytokine Response Are Associated with Subsequent Onset of Infections After Noncardiac Surgery
laudia D. Spies, MD*, Hartmut Kern, MD*, Torsten Schröder, MD*, Michael Sander, MD*, Henning Sepold, MD*, Philip Lang, MD*, Karl Stangl, MD, Steffen Behrens, MD, Pranav Sinha, MD, Walter Schaffartzik, MD||, Klaus-Dieter Wernecke, PhD¶, Wolfgang J. Kox, MD, PhD*, and Uday Jain, MSIT, PhD, MD#
Departments of *Anesthesiology and Intensive Care Medicine and Cardiology and Institute of Clinical Chemistry and Pathological Biochemistry, University Hospital
Anesth & Analg July 2002 95:9-18.
¥Øªº ¦b¦h¼Æ«D¤ßŦ¤â³N³N«á´¶¹M¦s¦b¤ß¦Ù¯Ê¦å¡]POMI¡^¡C¤â³N©MPOMI¥i¯à¼vÅT§K¬Ì¤O¡M¨Ï±wªÌ¹w«á´c¤Æ¡C§Ú̳q¹L¬ã¨s¥ÑPOMI½Õ¸`¦³Ãöªº¥Õ¤¶¯À¢w6¡]IL¢w6¡^©MIL¢w10¤Î¨ä»P³N«á·P¬V²v¬ÛÃö©Ê¡C¤èªk ¿ï¾Üªº203¨Ò¸¡³¡¡M¦åºÞ©M¾ã§Î¥~¬ì¤â³N¯f¤H¡C³ò³N´Á³B²z¤èªk¤@P¡C¦å¬y°Ê¤O¾Ç§ïÅܺû«ù¦b°ò¦Ȫº20%S³ò¤º¡C±q³Â¾K»¤¾É«e8¤p®É¶}©l¦Ü³N«á96¤p®É¦æHolter¤ß°Ê¹q¬y´y°O¾¹¨Ó§PÂ_POMI¡C¦b¤J°|¡M¤â³N«e¡M³Â¾K»¤¾É«e¡M¤â³N«á¡M¤JºÊÅ@«Ç¡M©M³N«á6¡M12¡M18¡M24¡M36¡M48¡M72¡M96¡M120¡M144¡M©M168¤p®ÉÀˬd12¾ÉÁp¤ß¹q¹Ï¡M¤ß¦Ù×QÃЩM§K¬Ì«ü¼Ð´ú©w¡C®Ú¾Ú¯e¯f±±¨î¤¤¤ß©Ò©w³W«h¶EÂ_·P¬V¡Cµ²ªG POMIµo¥Í²v¬°27%¡M¦h¼Æ¯f¨Ò¡]76%¡^µo¥Í¦b³N«á24¤p®É¤º¡CIL¢w6©MIL¢w10¤ô¥¦b¤â³N¤¤ÅãµÛª@°ª¡M¦ý¦bPOMI©M«DPOMI²Õ¤¤µL°Ï§O¡C³N«á¥X²{ÄY«·P¬V©Î±Ñ¦å¯g¡]n=47¡^¥§¡¬°3¤Ñ¡]S³ò±q1¢w8¤Ñ¡^¡M¦b¦¹Ãþ¯f¤H¤¤¡MPOMI²Õ¯f¤H³N¤¤IL¢w6©MIL¢w10¸û«DPOMI²Õª@°ª3¢w10¿¡C¦b³o¨ÇÄY«·P¬V¯f¤H¤¤¥Î¦h¦]¯À¤ÀªRªk¤ÀªRµo²{¡M¥~¬ì³Ð¶ËªºÃþ«¬»PIL¢w6ªºª@°ª¬ÛÃö¡M¦ÓIL¢w10ªºª@°ª»PPOMI¦³Ãö¡Cµ²½× ³o¨Çµo²{´£¥Ü¥ÑPOMI¤Þ°_ªº²ÓM¦]¤lªº§Y¨è¤ÏÀ³©M¤â³NÃþ«¬»PÄY«·P¬V©M±Ñ¦å¯gªºµo¥Í¬ÛÃö¡C
¡]©P¼ä Ķ ¤ý²»·ç®Õ¡^
Postoperative myocardial ischemia (POMI) is prevalent among patients after major noncardiac surgery. Surgery, as well as POMI, may modulate the immune system, potentially worsening patient outcome. We sought to investigate the modulation of soluble interleukin (IL)-6 and IL-10 by POMI and its association with increased postoperative infection rates. Two-hundred-three patients undergoing elective major abdominal, vascular, and orthopedic surgery participated in this prospective observational study. Perioperative management was standardized. Hemodynamic variables were kept within 20% of baseline. POMI was assessed by Holter electrocardiography starting at least 8 h before the induction of anesthesia and continued until 96 h after surgery. Twelve-lead electrocardiograms, cardiac enzymes, and immune variables were obtained at the time of admission to the hospital, before surgery, before the induction of anesthesia, after surgery, at the time of admission to the intensive care unit, and 6, 12, 18, 24, 36, 48, 72, 96, 120, 144, and 168 h after surgery. Infections were diagnosed according to the Centers for Disease Control criteria. The incidence of POMI was 27%, and the majority of cases (76%) occurred within the first 24 h after surgery. IL-6 and IL-10 levels significantly increased during surgery but did not differ between the POMI and Non-POMI groups. However, in the subset of patients who developed severe infections or sepsis (n = 47) a median of 3 days (range, 1¨C8 days) after surgery, the intraoperative increases of IL-6 and IL-10 in the POMI group were, respectively, 3 and 10 times higher compared with the increase in the Non-POMI group. By using a multifactorial analysis in these patients with severe infections, the type of surgical trauma was associated with an increased IL-6 response, whereas the increase in IL-10 was attributed to POMI. These findings suggest that immediate cytokine responses due to POMI and type of surgery might be relevant for the later onset of severe infections and sepsis.
¤C¬tîŹﰷ±d©M¤ß¦Ù¯fܹ«¥æ´À©Ê¥¿©Ê¦Ù¤O§@¥Î
The Paradoxical Positive Inotropic Effect of Sevoflurane in Healthy and Cardiomyopathic Hamsters
Benoît Vivien, MD*, Jean-Stéphane David, MD, Jean-Luc Hanouz, MD, PhD, Julien Amour, MD*, Yves Lecarpentier, MD, PhD, Pierre Coriat, MD*, and Bruno Riou, MD, PhD*||
¡@
*Laboratory of Experimental Anesthesiology, Department of Anesthesiology, Centre Hospitalier Universitaire (CHU) Pitié-Salpêtrière, Université Paris VI, Paris, France; Department of Anesthesiology, CHU Edouard Herriot, Lyon, France; Department of Anesthesiology, CHU Côte de Nacre, Caen, France; Department of Physiology, CHU de Bicêtre, and Institut National de la Santé et de la Recherche Médicale, Palaiseau, France; and ||Department of Emergency Medicine, CHU Pitié-Salpêtrière, Université Paris VI, Paris, France
Anesth & Analg July 2002 95:31-38
¥Øªº ¤ñ¸û¤C¬tîÅ¡]0.7~3.6vol%¡^¹ï°·±d©M°ò¦]»¤µo¤ß¦Ù¯fܹ«¥ª«Ç¨ÅÀY¦ÙªºÅܤO§@¥Î¡C¤èªk ¦bÅé¥~(29oC,pH7.40,Ca2+2.5mM,¨ë¿EÀW²v3¦¸/¤À)§Ct²ü(µ¥±i)©M°ªt²ü(µ¥®e)±ø¥ó¤U¡A¬ã¨s¤C¬tîŹﰷ±d©M°ò¦]»¤µo¤ß¦Ù¯fܹ«¥ª«Ç¨ÅÀY¦ÙªºÅܤO§@¥Î¡Cµ²ªG ¤C¬tîŹﰷ±dܹ«©M¤ß¦Ù¯fܹ«§¡²£¥Í¤¤«×¥¿©Ê¦Ù¤O§@¥Î¡]3.6vol%¤C¬tîŹﰷ±dܹ«¤ß¦Ù²£¥Íªºµ¥±i©Mµ¥®e³Ì¤jÁYµu³t²v¤À§O¬°115%¡Ó12%©M128%¡Ó21%¡AP<0.01¡F¦Ó¹ï¤ß¦Ù¯fܹ«¤ß¦Ù²£¥Íªºµ¥±i©Mµ¥®e³Ì¤jÁYµu³t²v¤À§O¬°115%¡Ó20%©M124%¡Ó31%¡AP<0.05 ¡C¤C¬tîŲ£¥Íªº¥¿©Ê¦Ù¤O§@¥Î¦b°·±d©M¤ß¦Ù¯fܹ«¤§¶¡µL®tÉÝ¡C¦bÀ³¥Î£\-µÇ¤W¸¢¨üÅéªýº¢¾¯©M£]-µÇ¤W¸¢¨üÅéªýº¢¾¯ªº±¡ªp¤U¡A¤C¬tîŲ£¥Íªº¥¿©Ê¦Ù¤O§@¥Î¦b¤GÃþܹ«¤§¶¡¤]µL¤£¦P¡C¦bÀ³¥Î¶t³q¹Dªýº¢¾¯ªº±¡ªp¤U¡A¤C¬tîŲ£¥Íªº¥¿©Ê¦Ù¤O§@¥Î¦b°·±dܹ«®ø¥¢¡A¦Ó¦b¤ß¦Ù¯fܹ«¼W±j¡C¦Ó¦b§Ct²ü©M°ªt²ü±¡ªp¤U¡A¤C¬tîŹï¤GÏúܹ«§¡²£¥Í¤¤«×t©ÊµÎ±i§@¥Î¡Cµ²½× ¤C¬tîŹﰷ±d©M¤ß¦Ù¯fܹ«²£¥Í¥Ù¬Þªº¥¿©Ê¦Ù¤O§@¥Î¡C
¡]¤ý¤h¹pĶ Éܤߨ}®Õ¡^
We investigated the effects of sevoflurane (0.7 to 3.6 vol%) on inotropy
and lusitropy in left ventricular papillary muscles of healthy
hamsters and genetically induced cardiomyopathic (strain BIO 14.6)
hamsters in vitro (29¢XC, pH 7.40, Ca2+ 2.5 mM, stimulation
frequency three per minute) under low (isotony) and high (isometry)
loads. Sevoflurane induced a moderate positive inotropic effect in
healthy hamsters (maximum unloaded shortening velocity and isometric
active force at 3.6 vol%: 115% ¡Ó 12% and 128% ¡Ó 21% of baseline
values, respectively; P < 0.01) and in cardiomyopathic
hamsters (maximum unloaded shortening velocity and isometric active
force at 3.6 vol%: 115% ¡Ó 20% and 124% ¡Ó 31% of baseline values,
respectively; P < 0.05). This positive inotropic effect did
not differ between healthy and cardiomyopathic hamsters, even when
sevoflurane concentrations were corrected for minimum alveolar anesthetic
concentration values in each strain, and was unchanged after
- and ß-adrenoceptor
blockade. After calcium-channel blockade, this positive inotropic
effect was abolished in healthy hamsters but enhanced in cardiomyopathic
hamsters. In both strains, sevoflurane induced a moderate negative lusitropic
effect under low and high loads.
¡@
Rapacuronium¹ï³Â¾K¤Iµ£ªÍÉó±ñªº¼vÅT¡GÉO¬üºûªQ¤ñ¸û
The Effect on Lung Mechanics in Anesthetized Children with Rapacuronium: A Comparative Study with Mivacurium
Gavin
F. Fine, MB, BCh*
, Etsuro K. Motoyama, MD*![]()
![]()
, Barbara W. Brandom, MD*
, Kathleen M. Fertal, BSN*, Rebecca Mutich, RRT
, and Peter J. Davis, MD*![]()
![]()
*Department of Anesthesiology and
Division of Pulmonology, Children¡¦s
Hospital of Pittsburgh; and the Departments of
Anesthesiology and
Pediatrics, University of
Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
Anesth & Analg July 2002 95:56-61
¥Øªº ¨Ï¥ÎRapacuronium¥i¼W¥[«æ©Ê¤äÉaºÞµjÅ˵o¥Íªº¦MÀI¡C¥»¤å³q¹L´ú©wªÍ¥\¯à¨Óª½±µÃÒ©úÀ³¥ÎRapacuroniumªº¤Iµ£¬O§_·|¥X²{Éa¹D¦¬ÁY¡C¤èªk ¥»¹êÅç¿ï¨ú10¦WASA¢¹-¢º±wªÌ¡]2-6·³¡^¡AÀHÉ󧡤À¬°¨â²Õ¡A¤À§Oµ¹¤©Rapacuronium©M¬üºûªQ¡C¥Î¤C¬tîŶi¦æ³Â¾K»¤¾É¡A«ùÄò¿é¤J¹p¦Ìªâ¤Ó¥§¡]0.2-0.3ug.kg-1.min-1¡^©MÉݤþ×ô¡]200-250 ug.kg-1.min-1¡^ºû«ù³Â¾K¡C¨C²Õ¶i¦æ¤TÓ¶¥¬qªºªÍ¥\¯à´ú¸Õ¡GªÍ¥\¯à°ò½u¼ÆÕu´ú©w¡FÀ³¥Î¦ÙªQÃĦZ©MÀ³¥Î£]2-¿E°Ê¾¯¦ZªÍ¥\¯àªº´ú©w¡C¨â²Õ¬Û¸û¡AÀR®§ª¬ºA©I§l¶¶À³©Ê¨S¦³µo¥ÍÅܤơCÀ³¥ÎRapacuronium¨ÏÁ`©I§l¨t²Îªý¤O¼W¥[¡A¦ý¨S¦³²Îp¾Ç¤Wªº·N¸q¡]¬°°ò½u¼ÆÈªº214.4%¡Ó122.65%¡AP≈0.1¡^¡C¬Û¤Ï10%¥Î¤OªÍ¬¡¶qªº³Ì¤j©IÉa¬y¶q¡]MEF10¡^©M¥Ñ¥Î¤O³qÉa§Þ³N´ú©wªº¬y¶q-®e¿n¦±½u¤¤ªºMEF¥\¯à§EÉa¶q¡]MEFFRC¡^§¡©úÅã°§C¡]¤À§O¬°53.4%¡Ó18.49%¡AP¡q0.01©M41.3%¡Ó27.42%¡AP¡q0.001¡r¡C¬üºûªQ²Õ¤¤©I§l¨t²Îªý¤O¨S¦³µo¥ÍÅܤơ]109.5%¡Ó30.28%¡^¡CMEF10»´·L°§C¡]77.0%¡Ó9.03%¡AP¡q0.005¡r¦ý¬OMEFFRC¨S¦³µo¥Í©úÅã§ïÅÜ¡]81.2%¡Ó29.85%¡AµL²Îp¾Ç·N¸q¡^¡Cµ¹¤©?/span>2-¿E°Ê¾¯¦Z¡A©Ò¦³ªººÊ´ú«ü¼Ð§¡¦^¨ì°ò½u¤ô¥¡Cµ²½× ÉO¬üºûªQ¬Û¸û¡A¨Ï¥ÎRapacuronium¥i¤Þ°_¸û»´ªºÉa¹Dªý¶ë¦P®É¹ïÀRºA©I§l¶¶À³©Ê¨S¦³¼vÅT¡C
¡]»¯³·½¬Ä¶ Éܤߨ}®Õ¡^
The administration of rapacuronium increases the risk of severe bronchospasm. There have been no studies of pulmonary function directly demonstrating airway constriction with rapacuronium in children. In this study, 10 ASA physical status I or II patients (aged 2-6 yr) were randomly divided into 2 equal groups, receiving either rapacuronium or mivacurium. Anesthesia was induced with sevoflurane and maintained with remifentanil (0.2~0.3 µg¡Pkg-1¡Pmin-1)and propofol (200~250 µg¡Pkg-1¡Pmin-1)infusions. We performed three sets of pulmonary function tests: baseline, after the administration of muscle relaxant, and after the administration of a ß2 agonist. In both groups, there were no changes in static respiratory compliance. The increase in total respiratory system resistance after the administration of rapacuronium did not reach statistical significance (214.4% ¡Ó 122.65% of baseline, P ≈0.1), whereas maximal expiratory flow at 10% of forced vital capacity (MEF)10 and MEFfunctional residual capacity on partial flow-volume curves by the forced deflation technique decreased markedly (53.4% ¡Ó 18.49%, P < 0.01 and 41.3% ¡Ó 27.42%, P < 0.001, respectively). With the administration of mivacurium, no changes were observed in respiratory system resistance (109.5% ¡Ó 30.28%). MEF10 decreased slightly (77.0% ¡Ó 9.03%, P < 0.005) whereas MEFFRC did not (81.2% ¡Ó 29.85%, not significant). After the administration of a ?sub>2 agonist, all measurements returned to baseline. Thus, the administration of rapacuronium consistently results in lower airway obstruction with minimal changes in static respiratory compliance when compared with mivacurium.
¡@
¡@
¥iÅs¦±¤ä®ðºÞÃè¼ÒÀÀ¾¹®ð¹D¼ÒÀÀ¾¹ªºªºµû¦ô
An Evaluation of a Virtual Reality Airway Simulator
Richard Rowe, MD, MPH*, and Ronald A. Cohen, MD
Departments of *Anesthesiology and Diagnostic Imaging, Children¡¦s Hospital Oakland, Oakland; and Departments of Anesthesiology and Radiology, University of California, San Francisco School of Medicine, San Francisco, California
Anesth & Analg July 2002 95:62-66.
¥Øªº
¦b¥»¬ã¨s¤¤¡M§ÚÌ´ú¸ÕAccuTough®¥iÅs¦±¤ä®ðºÞÃè¼ÒÀÀ¾¹¡]¼ÒÀÀ¾¹¡^ªº¨Ï¥Î¹ïÁ{§ÉÂå¥Í´x´¤¤p¨àÅÖ¤äÃè®ðºÞ´¡ºÞ¬O§_¦³¥Î¡C¤èªk ¿ï¾Ü¥H©¹¥¼¥Î¹LÅÖ¤äÃ誺¤p¨à¬ì¦í°|Âå¥Í¡C¦í°|Âå¥Í¦b¥þ³Â¤U¹ï¤p¨à¦æÅÖ¤äÃè´¡ºÞ¡C¹ï´¡ºÞ¿ý¶H±a°µ¥H¤U¤ÀªR¬ã¨s¡R¬Ý¨ì®ðºÞ¶©¬ðªº®É¶¡¡M¤ä®ðºÞÃèÀYºÝIJ¤ÎÂH½¤ªº¦¸¼Æ©M®É¶¡¡CµM«á¦b¼ÒÀÀ¾¹¹ï¦í°|Âå¥Í¶i¦æ°V½m¡C»P¤U¤@Ó¤p¨àªºÅÖ¤äÃè´¡ºÞ¶i¦æ¤ñ¸û¡C¦b¨â¦¸¶¡¶È±µ¨ü¼ÒÀÀ¾¹ªº°V½m¡Cµ²ªG ¹ï·Ó²Õ¦b¨â¦¸´¡ºÞ¶¡¤£±µ¨ü¼ÒÀÀ¾¹ªº°V½m¡C¦í°|Âå¥Í¨Ï¥Î¼ÒÀÀ¾¹½m²ß¤F¥§¡17¦¸¡M¯Ó®É39¤ÀÄÁ¡C¦b¨Ï¥Î¼ÒÀÀ¾¹«á¾Þ§@©úÅã§ïµ½¡C¥Ñ¤ä®ðºÞÃ覨¥\§¹¦¨´¡ºÞªº®É¶¡±q5.15¤ÀÄÁ´î¤Ö¦Ü0.88¤ÀÄÁ¡]P<0.001¡^¡C¤ä®ðºÞÃèÀYºÝIJ¤ÎÂH½¤ªº¦¸¼Æ¥Ñ21.4´î¦Ü3.0¡]P<0.001¡^¡C¬Ý¨£ÂH½¤ªº®É¶¡¥Ñ2.29°¦Ü0.19¤ÀÄÁ¡]P<0.001¡^¡C¬Ý¨£®ð¹Dªº¦¸¼Æ¦Ê¤À¤ñ±q58.5%¼W¥[¦Ü80.4%¡]P=0.004¡^¡Cµ²½× ¤ä®ðºÞÃè¼ÒÀÀ¾¹¹ï¦í°|Âå¥Í´x´¤ÅÖ¤äÃè´¡ºÞ¬O¦³®Äªº¡C¥¦¥iÅãµÛ´£°ª§¹¦¨®ðºÞ´¡ºÞ©M¨ä¥L¾Þ§@©Ê¯à«ü¼Ð¡C
¡]©P¼ä Ķ ¤ý²»·ç®Õ¡^
In this research, we sought to test the hypothesis that the AccuTouch® Flexible Bronchoscopy Simulator (Simulator) is an effective way to teach clinicians the psychomotor skills necessary to use the fiberoptic bronchoscope as an instrument for intubating the trachea of a pediatric patient. Pediatric residents with no prior experience in fiberoptic bronchoscopy were studied. Residents performed fiberoptic intubation on children undergoing general anesthesia. Tapes of these intubations were analyzed for: time to visualization of the carina, and number and time that the bronchoscope tip hit the mucosa. Residents were then trained on the Simulator. Performance of fiberoptic intubation on a subsequent child was compared. Training on the Simulator was the only instruction that the residents received between the two cases. A control group of residents performed two consecutive intubations without training on the Simulator between cases. Residents studied an average of 17 cases, and spent 39 min on the Simulator. Performance was markedly improved after the Simulator. Time to completion of successful intubation with a bronchoscope was reduced from 5.15 to 0.88 min (P < 0.001). The number of times that the tip of the bronchoscope hit the mucosa was reduced from 21.4 to 3.0 (P < 0.001). The amount of time that the resident spent viewing the mucosa decreased from 2.24 to 0.19 min (P < 0.001). The percent of time viewing the channel of the airway increased from 58.5% to 80.4% (P = 0.004). This bronchoscopy simulator was very effective in teaching residents the psychomotor skills necessary for fiberoptic intubation. Significant improvement was seen in time to completion of endotracheal intubation, as well as other performance indicators.
Awareness and Recall in Outpatient Anesthesia
Johanna
Wennervirta, MD*, Seppo O.-V. Ranta, MD*, and Markku Hynynen,
MD, PhD![]()
*Department of Anesthesia and Intensive Care Medicine, Helsinki University
Central Hospital, Children¡¦s Hospital, Helsinki, Finland; and
Department of Anesthesia
and Intensive Care, Helsinki University Central Hospital, Jorvi Hospital, Espoo,
Finland
Anesth & Analg July 2002 95:72-77
¥Øªº ¬ã¨sªù¶E¯f¤H³Â¾Kª¾¾å©M¦^¾Ðªºµo¥Í²v¡A¦}ÉO¦í°|¯f¤H¶i¦æ¤ñ¸û¡C¤èªk ¦b14.5Ó¤ë´Á¶¡¡A§Ú̽լd¤F1500¨Òªù¶E¯f¤H©M2343¨Ò¦í°|¯f¤H³Â¾Kª¾¾å©M¦^¾Ðªºµo¥Í±¡ªp¡Cµ²ªG ¦³5¨Òªù¶E¯f¤H¥X²{³Â¾Kª¾¾å©M¦^¾Ð¡A¨ä¤¤1¨Ò¬°²M´·¦^¾Ð¡A¥t¥~4¨Ò¬°¼Ò½k¦^¾Ð¡C¦Ó¦b¦í°|¯f¤H¤¤¦³6¨Ò¥X²{³Â¾Kª¾¾å©M¦^¾Ð¡A¨ä¤¤²M´·¦^¾Ð©M¼Ò½k¦^¾Ð¦U¥e3¨Ò¡Cªù¶E¯f¤H©M¦í°|¯f¤H²M´·¦^¾Ðªºµo¥Í²v¤À§O¬°0.07%©M0.13%,¸g²Îp¾Ç³B²zµLÅãµÛ©Ê®tÉÝ¡C¥X²{³Â¾Kª¾¾å©M¦^¾Ðªºªù¶E¯f¤HÀ³¥Î¤C¬tîŪº¶q¸ûµLª¾¾å©M¦^¾ÐªÌ¤Ö¡]p¡q0.05¡r¡Cµ²½× ³Â¾Kª¾¾å©M¦^¾Ð¬O¥þ³Â´Á¶¡¤Ö¨£ªº¦}µo¯g¡A¦Óªù¶E¯f¤H©M¦í°|¯f¤H¬Û¤ñ¡A¥X²{³Â¾Kª¾¾å©M¦^¾Ðªº¦MÀI©Ê¦}µL¼W¥[¡C
¡]¤ý¤h¹pĶ Éܤߨ}®Õ¡^
We studied the incidence of awareness and explicit recall during general anesthesia in outpatients versus inpatients undergoing surgery. During a 14.5-mo period, we structurally interviewed 1500 outpatients and 2343 inpatients. Among outpatients, there were five cases of awareness and recall (one with clear intraoperative recollections and four with doubtful intraoperative recollections). Of the inpatients, six reported awareness and recall (three with clear and three with doubtful intraoperative recollections). The incidence of clear intraoperative recollections was 0.07% in outpatients and 0.13% in inpatients. The difference in the incidence was not significant. Among outpatients, those with awareness and recall were given smaller doses of sevoflurane than those without awareness and recall (P < 0.05). In conclusion, awareness and recall are rare complications of general anesthesia, and outpatients are not at increased risk for this event compared with inpatients undergoing general anesthesia.
¡@
£\-7·ÏÆP«¬¤AýHÁxÆP¨üÅé¹ïÉݬtîŪº±Ó·P©Ê¦³¿à¨üÅ饢¬¡ºA
Sensitivity of the £\-7 Nicotinic Acetylcholine Receptor to Isoflurane May Depend on Receptor Inactivation
Pamela Flood, MD, FACA, and Kristen M. Coates, BS
Department of Anesthesiology, Columbia University, New York
Anesth & Analg July 2002 95:83-87
¥Øªº §ÚÌ´¿¸gÃÒ¹ê¡A·íÉݬtîŪº¿@«×¹F¨ì640µM¡]2¿ªºMAC¡^®É¡A±N·|¼vÅT£\-7·ÏÆP«¬¤AýHÁxÆP¨üÅé(£\-7 nAChR)¥\¯à¡A¦Ó£\-7nAChR¼sªx¤À¥¬¤_¤¤¼Ï©M¥~©P¯«¸g¨t²Î¡A³q¹L¬ðàD«e©M¬ðàD¦Z¤è¦¡¼vÅT¬ðàD«H¸¹¶Ç»¼¡A³o¼Ë¡AÉݬtîŹï£\-7 nAChR ¬¡©Êªº½Õ¨î¥i¯à¬O¨ä¥Dn³Â¾KÉó¨î¤§¤@¡C¥»¦¸¹êÅ礤¡A§Ú̶i¤@¨B¬ã¨sÉݬtîŹï£\-7 nAChR ªºÃIJz§@¥Î¯S©º¡C¤èªk À³¥Î¤À¤l¥Íª«¾Ç§Þ³N¡A§Q¥Î¤öµì§Z¥À²ÓMªí¹F¨t²Îªí¹FÂû©M¤Hªº£\-7 nAChR¡A¥ÎÂù¹q·¥¹qÀ£¹X§Þ³N¡A¬ã¨s¤F¤£¦PªºÉݬtîŹwÄéª`®É¶¡¡B¤£¦Pªº¿E°Ê¾¯¿@«×©M¤£¦Pªº½¤¹q¦ì¤ô¥¤UÉݬtîŹï£\-7 nAChR ªº§í¨î§@¥Î¡Cµ²ªG ¦b¤@©wªº¹q¥Í²z±ø¥ó¤U¡AÁ{§É¬ÛÃö¿@«×ªºÉݬtîÅ¥i§í¨î£\-7 nAChR ¬¡©Ê¡C·í¿E°Ê¾¯¿@«×¼W°ª¥H¤ÎÉݬtîŹwÄéª`®É¶¡©µªø®É¡A§í¨î§@¥Î¼W±j¡C¦b¥ÎÉݬtîŹwÄéª`¡A¥Î100µM¤AýHÁxÆP¿E°Ê¨üÅ骺±ø¥ó¤U¡AÉݬtîŹïÂûnAChR ªº¥b¼Æ³Ì¤j§í¨î¿@«×¬°938¡Ó 26µM¡A¦Ó¥Î1 mM¤AýHÁxÆP¿@«×®É¡AÉݬtîŹïÂûnAChR ªº¥b¼Æ³Ì¤j§í¨î¿@«×¬°408¡Ó51µM¡Cµ²½× ¿E°Ê¾¯¿@«×¼W°ª¥H¤ÎÉݬtîŹwÄéª`®É¶¡©µªø®É¡AÉݬtîŹ蠟§í¨î¼W±j¡A¦¹²{¶H´£¥Ü¡AÉݬtîÅ¥Dn§@¥Î¤_nAChR ªº³q¹DÃö³¬ºA©ÎÃö³¬-²æ±ÓºA¡C
¡]·¨«O¥òĶ Éܤߨ}®Õ¡^
In previous studies, we demonstrated that nicotinic acetylcholine receptors (nAChRs) composed of the £\-7 subunit are unaffected by the co-application of isoflurane with agonists at concentrations up to 640 µM(two times the minimum alveolar anesthetic concentration). Modulation of £\-7-nAChR activity by isoflurane might have important behavioral ramifications because these receptors are expressed diffusely in the central and peripheral nervous systems and play pre- and postsynaptic roles in synaptic transmission. Here we have demonstrated that under some potentially physiologically relevant circumstances, the activation of £\-7 nAChRs may be inhibited by clinically relevant concentrations of isoflurane. We evaluated isoflurane inhibition of £\-7 nAChRs from chicks and humans expressed in Xenopus oocytes using two-electrode voltage clamp methodology. We determined the influence of time of preperfusion of isoflurane, agonist concentration, and membrane potential on inhibition by isoflurane. Both activation by a large concentration of agonist and isoflurane preperfusion increased inhibition. The half-maximal inhibitory concentration for isoflurane inhibition of chick £\-7 nAChR with isoflurane preperfusion and activation by 100 µM of acetylcholine was 938 ¡Ó 26, and when activated by 1 mM of acetylcholine, it was 408 ¡Ó 51 µM. The increase in inhibition with isoflurane preexposure and large agonist concentration raises the possibility that isoflurane interacts preferentially with a closed or closed-desensitized state of the channel.
¡@
¡@
¹q°w¨ë¿E¨¬¤T¨½¡M¶§³®¬u¡M©ø¨Ú¤T¥Þ¦ì¨Ã¤£´î¤Ö³Â¾KÃĥζq
Electro-Acupuncture at the Zusanli, Yanglingquan, and
Kunlun Points Does Not Reduce Anesthetic Requirement
Nobutada Morioka, MD*,Ozan Akca, MD*, Anthony G. Doufas, MD, PhD*, Gregory Chernyak, MD*, and Daniel I. Sessler, MD#
*Department of Anesthesiology, University Louisville, Kentueky. #Ludwig Boltzmann Institute,University of Vienna, Austria.
Anesth & Analg July 2002 95:98-102
¥Øªº
¥»¤å¸Õ¹ÏÅçÃÒ¹q°w¨ë¿E¨¬¤T¨½¡M¶§³®¬u¡M©ø¨Ú¤T¥Þ¦ì¥i¥H´î¤Ö³Â¾KÃıo¥Î¶q¡C¤èªk14¦ì¦~»´¡M°·±dªº§ÓÄ@ªÌ¡M¦b¤£¦P¨â¤Ñ¤º¤À§O¨Ï¥Î¦a¬tîų¾K¡C°wª¬¹q·¥¸m¤_»L¤W¦¹¤T¥Þ¦ì³B¡M¸Õ¹ÏÀò±o¥þ¨©ÊªºÂíÀR©MÂíµh®ÄÀ³¡C¦b¸ÕÅç´Á¤º¡M¹q°w¬ï³z¥Ö½§¨ë¤J¦¹¤T¥Þ¦ì¡M¦Ó¦b¹ï·Ó´Á¤º«h©Þ¥X¡C¦b¨ü¸Õ´Á¤¤¸g¹q·¥µ¹¤©¹q¨ë¿E¡M
2¬íªº¶¡»Ø¥æ´Àµ¹¤©±j«×¬°2Hz©M100Hzªº¨ë¿E¡C·í©I®ð¥½¦a¬tîÅ¿@«×¹F¨ì5.5%¨Ãéw15¤ÀÄÁ®É¡M¦bÂù»L¤W¥Ñ25¸¹°wµ¹¤©«ùÄò10¬í70mA¡M100Hzªº¨ë¿E¡C¦p¨ü¸ÕªÌ¦³°Ê§@«h±N¦a¬tîÅ¿@«×ª@°ª0.5%¡M¦p¸ÕÅçªÌ¤£°Ê«h±N¦a¬tîÅ¿@«×´î¤Ö0.5%¡C§P©w¨ü¸ÕªÌ¬O§_²¾°Êªº½Õ¬dªÌ¹ïªvÀø±¡ªp¨Ã¤£ª¾±¡¡C³o¤@¤W¤U½Õ¸`¿@«×ªº¸ÕÅç±N«ùÄòª½¦Ü¨ü¸ÕªÌ±q°Ê¨ì¤£°Ê¤Ï´_½ü¦^4¦¸¡Cµ²ªG
¸g¦^Âk¤ÀªR¡M±N¦b¹q¨ë¿E®É50%¦³²¾°Êªº¦a¬tîÅ¿@«×½T»{¬°¦a¬tîų¾K³Ì§CªÍªw¿@«×¡C¦b¹q¨ë¿E²Õ¡]4.6%¡Ó0.6%¡^»P¹ï·Ó²Õ¡]4.6%¡Ó0.8%¡^¶¡¡M³Ì§C¦a¬tîŪͪw³Â¾K¿@«×µL©úÅã®t²§¡]P=0.8¡^¡Cµ²½×
³o¨Ç¼Æ¾Ú´£¥Ü¥iÀË¥X²Õ¶¡®t§O¬°0.35®e¿n¦Ê¤À¤ñªº·§²v¬°80%¡C
¡]Êã¬öµØ
Ķ
¤ý²»·ç®Õ¡^
We tested the hypothesis that electro-acupuncture at the Zusanli, Yanglingquan, and Kunlun acupuncture points on the legs decreases anesthetic requirement. Fourteen young, healthy volunteers were anesthetized with desflurane on two separate days. Needle electrodes were positioned at the three acupuncture points thought to produce a generalized sedative and analgesic effect. Needles were percutaneously placed on treatment days; on control days, they were insulated and taped near the insertion points. The electrodes were stimulated on the treatment day. Stimulation consisted of 2-Hz and 100-Hz currents alternated at 2-s intervals. When the end-tidal desflurane concentration of 5.5% was stable for 15 min, noxious electrical stimuli were administered via 25-gauge needles on both thighs (70 mA at 100 Hz for 10 s). Desflurane concentration was increased 0.5% when movement occurred and decreased 0.5% when it did not. An investigator, blinded to treatment, determined movement. These up-and-down sequences were continued until volunteers crossed from movement to no movement four times. A logistic regression determined the partial pressure of desflurane that produced a 50% likelihood of movement in response to noxious stimulation and consequently identified the minimum alveolar anesthetic concentration equivalent for desflurane. There was no significant difference in minimum alveolar anesthetic concentration equivalents between the electro-acupuncture (4.6% ¡Ó 0.6%, mean ¡Ó SD) and control (4.6% ¡Ó 0.8%) days (P = 0.8). These data provided an 80% power for detecting a difference of 0.35 volume-percent between the groups.
¤p¾¯¶q´âÓiଥi§ïµ½³N«á¯f¤H§íÆ{ª¬ºA
Small-Dose
Ketamine Improves the Postoperative State of Depressed Patients
Akira Kudoh, MD*,Yoko Takahira, Hiroshi Katagai, MD, Tomoko Takazawa, MD
*Department of Anesthesiology, Hakodate Watanabe Hospital; and department of Anesthesiology, Hirosaki National Hospital, Hirosaki, Aomori, Japan
Anesth & Analg July 2002 95:114-118.
¥Øªº
¥»¬ã¨s±´°Q´âÓiବO§_¾A©y¤_¦³§íÆ{ª¬ºA¾ã§Î¥~¬ì¤â³N¯f¤H¡C¤èªk70¦W¦³§íÆ{±¡ºüªº¦¨¦~¯f¤H©M25¦W¹ï·Ó²Õ¡]C²Õ¡^¡C§íÆ{¯f¤HÀH¾÷¤À¬°2²Õ¡M³Â¾K»¤¾ÉA²Õ¡]n=35¡^¥Î²§¤þ×ô¡Mªâ¤Ó¥§¤Î´âÓiଡMB²Õ¡]n=35¡^¥Î²§¤þ×ô¤Îªâ¤Ó¥§¡C©Ò¦³¯f¤H§l¤J1.5%-2.0%²§¬tîŤίº®ðºû«ù³Â¾K¡Cµ²ªG
³N«e2¤ÑHamilton
Depressed Rating(HDR)¥§¡µû¤À¦bA²Õ¬°12.7¡Ó5.4¡MB²Õ¬°12.3¡Ó6.0¡C³N«á1¤ÑA²ÕHDRµû¤À¬°9.9¡Ó4.1¦ÓB²Õ¬°14.4¡Ó3.8¡C³N«á1¤ÑA²ÕHDRµû¤ÀÅãµÛ§C¤_B²Õ¡]P<0.05¡^¡CC²ÕHDRµû¤À¦b³N«e2¤Ñ¬°4.2¡Ó1.7¡M³N«á1¤Ñ¬°4.8¡Ó1.6¡C»PB²Õ¬Û¤ñ¡MA²Õ¯f¤Hªº§íÆ{±¡ºü¡M¦Û±þ¶É¦V¡MµJ¼{¤£¦wµ¥¦³©úÅã°§C¡CA²Õ¯f¤H³Â¾K«á8¤p®É¡]26.6¡Ó8.7¡^©M16¤p®É¡]24.9¡Ó8.2¡^ªº¯kµhµû¤ÀnÅãµÛ§C¤_B²Õ¯f¤H8¤p®É¡]34.3¡Ó12.0¡^©M16¤p®É¡]31.1¡Ó8.8¡^ªº¯kµhµû¤À¡]P<0.05¡^¡Cµ²½×
¤p¾¯¶q´âÓiଥi¥H§ïµ½§íÆ{¯f¤H³N«áªº§íÆ{ª¬ºA¡M¨Ã´î»´¨ä³N«á¯kµh¡C
¡]Êã¬öµØÄ¶ ¤ý²»·ç®Õ¡^
We investigated whether ketamine is suitable for depressed patients who had undergone orthopedic surgery. We studied 70 patients with major depression and 25 patients as the control (Group C). The depressed patients were divided randomly into two groups; patients in Group A (n = 35) were induced with propofol, fentanyl, and ketamine and patients in Group B (n = 35) were induced with propofol and fentanyl, and all patients were maintained with 1.5%¡V2.0% isoflurane plus nitrous oxide. The mean Hamilton Depression Rating (HDR) score was 12.7 ¡Ó 5.4 for Group A and 12.3 ¡Ó 6.0 for Group B 2 days before surgery and 9.9 ¡Ó 4.1 for Group A and 14.4 ¡Ó 3.8 for Group B 1 day after surgery. The HDR score in Group A 1 day after surgery was significantly (P < 0.05) lower than that in Group B. The HDR score in Group C was 4.2 ¡Ó 1.7 2 days before surgery and 4.8 ¡Ó 1.6 1 day after surgery. Depressed mood, suicidal tendencies, somatic anxiety, and hypochondriasis significantly decreased in Group A as compared with Group B. Postoperative pain scores in Group A at 8 and 16 h after the end of anesthesia were 26.6 ¡Ó 8.7 and 24.9 ¡Ó 8.2, respectively, which were significantly (P < 0.05) lower than 34.3 ¡Ó 12.0 and 31.1 ¡Ó 8.8 in Group B. In conclusion, small-dose ketamine improved the postoperative depressive state and relieved postoperative pain in depressed patients.
µ[¬ÄÁxÆP¯à¦w¥þ¥Î¤_°ª¹[¦å¯gªº¯f¤H¶Ü¡S
Can Succinylcholine Be Used Safely in Hyperkalemic Patients?
Adam
J. Schow, MD*, David A. Lubarsky, MD, MBA
, Ronald P. Olson, MD*, and Tong J. Gan, MB*
*Department of Anesthesiology, Duke University Medical Center, Durham, North
Carolina; and
Department of Anesthesiology, University of Miami/Jackson
Medical Center, Florida Anesth & Analg July 2002 95:119-122
I´º ºÉºÞ²{¦bÁÙ¨S¦³¨t²Îªº¸ê®ÆÚÌ©w¦å¹[³B¤_¦óÏú¤ô¥¬O¦w¥þªº,°ª¹[¦å¯g±`³Q»{¬°¬Oµ[¬ÄÁxÆPªº¬Û¹ï¸T§ÒÃÒ¡C¥Øªº ¬ã¨s¦b±w¦³°ª¹[¦å¯gªº¯f¤H¤¤À³¥Îµ[¬ÄÁxÆP¬O§_¦w¥þ¡C¤èªk ¦^ÅU©Ê¦a½Õ¬d¤F¶W¹L¥|¸U¨Ò»¤¾É®É¨Ï¥Î¤Fµ[¬ÄÁxÆPªº¥þ³Â¯f¤H¡M®É¶¡¸ó«×¶W¹L70Ó¤ë¡Cµ²ªG ¨ä¤¤38¤H³N«e¦å²M¹[¿@«×¶W¹L5.6 mEq/L¡C³o¨Ç¯f¤Hªº³Â¾K¥Í¦s²v¬O100%¡C³q¹L¤H¤u½Õ¬d¥H¤ÎÀˬd³N¤¤¦Û°Ê¥Í¦¨ªº³Â¾K°O¿ý©M³N«á¯fµ{°O¿ý§¡¥¼µo²{¦³¤ß«ß¤£»ô©Î¨ä¥¦ÄY«¨Öµo¯gªº°O¸ü¡C¸g¹L²Îp³B²z¡M95%¥i«H°Ï¶¡³Ì¤j·ÀI²v¬O7.9¢H¡C·íµM³oÓ¤ñ¨Ò¬O¤£®e©¿µøªº¡C¦ý¬O³oӼƾڴX¥G¥i¥HªÖ©w°ª¦ô¤F¤¤µ¥µ{«×ªº°ª¹[¦å¯gªº¦MÀI¡Cµ²½× ±ý³q¹L«e¤©Ê¬ã¨s½T©w°ª¹[¦å¯gªº¦w¥þ½d³ò¬O§xÃøªº¡C©Ò¥H²{¦³ªº³o¨Ç¼Æ¾Úªí©ú¡M¦b»Ýnºò«æ´¡ºÞ¤S¤£¯à¦³ªø®É¶¡¦Ù¦×·ò·ôªº±¡ªp¤U¡M¹ï©ó¤¤µ¥°ª¹[¦å¯gªº¯f¤H¡MÀ³¥Îµ[¬ÄÁxÆPÁÙ¬O¦w¥þªº¡C
(ÃCÀÜĶ ²ø¤ß¨}®Õ)
The use of succinylcholine in hyperkalemic patients (serum potassium >5.5 mEq/L) is often viewed as relatively contraindicated, although there are no systematic data to define what preoperative potassium level is safe. We retrospectively reviewed more than 40,000 general anesthetics administered over 70 mo in which succinylcholine was given at the induction. This search yielded 38 patients with a preoperative potassium of 5.6 mEq/L or greater. Survival of the anesthetic was 100%, and no dysrhythmias or other major morbidity were documented upon manual review of the intraoperative automated record keeper charts or the patient medical records. These data allow a 95% confidence interval assessment of maximal risk for an event of 7.9%, which is not negligible, but which almost certainly grossly overestimates the risk for patients with moderately increased potassium levels. A prospective trial to definitively assess the safety margin for succinylcholine use in hyperkalemic patients would be difficult. Therefore, these data, taken in the context of a compelling case for rapid intubating conditions without long-term paralysis, suggest safety in succinylcholine use in patients with modest hyperkalemia.
¹ï°ü¬ì³N«e©M³N«á¯kµhµû¦ôªº¤@ºØ¦³®Ä¥i¾aªº·s¤èªk
A New Highly Reliable Instrument for the Assessment of Pre- and Postoperative Gynecological Pain
Elisabet
Stener-Victorin,RPT,PhD*, Jan Kowalski, BS, and Thomas Lundeberg,MD,PhD
·ç¨åºq¼w³ù¤j¾Ç°ü²£¬ì¾Ç¨t¡Q´µ¼wôº¸¼¯Karolinska¾Ç·|¥Í²z¾Ç©MÃIJz¾Ç¤À·|¡Q·ç¨å´µ¼wôº¸¼¯KarolinskaÂå°|Ãľ¯
Anesth & Analg July 20002 95:151-157.
¥Øªº
¦b¥»¤å¤¤§Ú̦bµu¤p°ü¬ì¤â³N¤¤¹ï¤@¶µ·sªº¯kµhµû¦ô¤èªkªº¥i¾a©Ê¶i¦æÅçÃÒ¡C¤èªk³o¤@¤èªk«Ø¥ß¦b¯kµh¤Ç°t¹ïª¾Ä±¤Ç°t¤ñ¸û°ò¦¤W¡C¥t¥~¡M¹ï¨Ï¥Î¨âºØ¤£¦P³Â¾K¤èªk¢w¢w¹q¨ë¿E©Î§Ö³tªü¤ùÃþÃĪ«¦pªüªâ¤Ó¥§¡M¨â²Õ¦P®É¦X¥Î®cÀV®Çªýº¢¡M¦b³N«e©M³N«á2¤p®É¨Ï¥Î¯kµh¤Ç°t©MVASµû¤À¶i¦æ¯kµhµû¦ô¡C¦³223¦W¤k¯f¤H¡]22-38·³¡^°Ñ»P¤F³o¤@´ú¸Õ¡Cµ²ªG
¯kµh¤Ç°t¬O¤@ºØ¥i¾aªº¯kµhµû¦ô¤èªk¡C¦³Ó§O¯f¤H¤£Ä@·N°Ñ¥[¦¹¶µ´ú¸Õ¡M¦ý³o¨Ã¤£¼vÅT¥»¤åµ²ªGªº²Îp¾Ç·N¸q¡CÂX¤jªº¶¥±èµ{§Ç(rank-order
coefficient,ra)¨t¼ÆÈ¤Q¤À²z·Q¡]0.95-1.00¡^¡C·í¨è«×¥Î¤_±´ª¾¯kµhª¬ºAªº§ïÅܮɡM¨Ã¨S¦³©úÅ㪺¸ñ¶HÅã¥Ü¦³¦ó¤ÏÀ³¡C³o¥i¯à¥Dn¬O¥Ñ©ó¼Æ¾Ú²Îp®ÉµLªkÅU¤ÎÓ§Oªº±¡ªp¡C¥Ñ©óÓ§O±¡ªp¾ÉPªº®t²§¦b¯kµh¤Ç°t´ú¶q®Én¤p©óVASµû¤À¡CÁ`¦Ó¨¥¤§¡M§Ú̵o²{¯kµh¤Ç°t¬O¤@ºØ«Ü¦nªº´ú¶q¯kµhªº¤èªk¡M¨äµ²ªG¥i¾a¡M¤Ï´_´ú¶q®É®t²§¤ñVASµû¤À¤p¡Cµ²½×
¯f¤H¯à«Ü¦n¦a±µ¨ü¯kµh¤Ç°t´ú¶q¡M³o¦b´ú¶q«æ©Ê³N«e©M³N«á¯kµh®É¬O«D±`¦³¥Îªº¡C
¡]Êã¬öµØ Ķ ¤ý²»·ç®Õ¡^
In this study, we evaluated the reliability of a newly developed method for pain assessment, which is based on perceptual matching by Pain Matcher® Cefar Medical AB, Lund, Sweden, during minor gynecological surgery. In addition, the responsiveness to two different anesthetic methods¢welectro-acupuncture or a fast-acting opiate, alfentanil, both in combination with a paracervical block¢wwas estimated by using Pain Matcher and visual analog scale (VAS) assessments before and 2 h after surgery. Two hundred-twenty-three women (aged 22¡V38 yr) participated. The results show that Pain Matcher is a reliable method for pain assessments, with lack of random individual disagreement and with no statistical evidence of systematic disagreement in position or in concentration. The augmented rank-order coefficient (ra) values were excellent (0.95¡V1.00). When scales were used to detect true changes over time, there was no clear indication of responsiveness, mostly because of statistically significant random individual changes. However, the individual changes were much smaller for magnitude matching than for VAS. In conclusion, we would recommend the use of perceptual matching by Pain Matcher for pain assessment, because in this study it was a reliable and powerful in test-retest situations and had smaller individual changes than VAS after intervention. The Pain Matcher procedure was well accepted by the patients, and the results suggest that it may be useful when evaluating acute pre- and postoperative pain.
¡@
¡@
¸¡¦¡¥þ¤l®c¤Á°£³N«á¤_¸¡½¤¤º©M¤Á¤fÀ³¥Î¥¬¤ñ¥d¦]¥[µÇ¤W¸¢¯ÀªºÂíµh®ÄÀ³
The Analgesic Effects of Intraperitoneal and Incisional Bupivacaine with Epinephrine After Total Abdominal Hysterectomy
A.Ng, FRCA*, A. Swami, FFARCSI*, G. Smith, MD, FRCA*, A.C. Davidson, FRCOG, and J. Emembolu, FRCOG
*University Department of Anaesthesia, Critical Care, and Pain Management, and Department of Obstetrics and Gynaecology, Leicester Royal Infirmary, Leicester LE1 5WW, United Kingdom
Anesth & Analg July 2002 95:158-162
¥Øªº ¥»¬ã¨sÆ[¹î¸¡¦¡¥þ¤l®c¤Á°£³N«á¤_¸¡½¤¤º©M¤Á¤fÀ³¥Î¥¬¤ñ¥d¦]¥[µÇ¤W¸¢¯À²£¥ÍªºÂíµh®ÄÀ³¡C¤èªk 46¨ÒASAI-II¯Åªº¯f¤H±µ¨ü±`³W³Â¾K¡M³N²¦¦æ¯f¤H¦Û±±¶Ü°Ø¥H¤Î¨C6¤p®É¸gª½¸zµ¹¤©¥·¼ö®§µh1gÂíµh¡C¯f¤H³QÀH¾÷¤À¬°¨â²Õ¡M¤@²Õµ¹¤©50ml 0.25%¥¬¤ñ¥d¦]½Æ¦X5ug/mlµÇ¤W¸¢¯À¡Q¥t¤@²Õµ¹¤©50ml¥Í²zÆQ¤ô§@¬°¹ï·Ó²Õ¡C¦bÃö³¬¶Ë¤f«e±N¨ä¤¤30mlÀ³¥Î¤_¸¡½¤¤º¡M¥t¥~20mlÀ³¥Î¤_¤Á¤f¡Cµ²ªG ¦w¼¢¾¯²Õªº17¨Ò¯f¤H©M¥¬¤ñ¥d¦]²Õªº16¨Ò¯f¤H¤À§O§¹¦¨¤F¥»¬ã¨s¡C³¡¥÷¯f¤H¨S¦³§¹¦¨¥»¬ã¨s¬O¦]¬°PCA¬G»Ù¡NPCA¤¤¤î¤Ó¦¡N´c¤ß¡N¯Ý³¡·P¬V¡N©ñ¸m¤F¸¡µÄ¤º¤Þ¬yºÞ¥H¤Î¹H¤Ï¨óij¡C¨â²Õ¯f¤H¦b¦~ÄÖ¡N¨°ª¡NÅ髩Τâ³N®É¶¡¤è±µL©úÅã®t²§¡C²M¿ôª¬ºA¤U¦w¼¢¾¯²Õªº¯f¤H¬¡°Ê«á¯kµh©úÅã¤ñ¥¬¤ñ¥d¦]²Õ¯f¤H±j¯P¡C¦w¼¢¾¯²Õ¯f¤H24¤p®É¶Ü°Ø¥Î¶q¬°62mg (53-85mg)¡M¦Ó¥¬¤ñ¥d¦]²Õ¬°44mg (33-56mg) (p<0.01)¡C°Q½× ¨â²Õ24h¶Ü°Ø¥Î¶q©úÅã®t²§¥Dn¬O¦]¬°¦w¼¢¾¯²Õ¯f¤H¦b³N«á²Ä¤@Ó4¤p®É¤ºªº¶Ü°Ø¥Î¶q¸û¤j¡Cµ²½× ¸¡¦¡¥þ¤l®c¤Á°£³N«á¤_¸¡½¤¤º©M¤Á¤fÀ³¥Î¥¬¤ñ¥d¦]¥[µÇ¤W¸¢¯À¡M¦b²Ä¤@Ó4¤p®É¨ã¦³©úÅãÂíµh®ÄªG¡M¥i©úÅã´î¤Ö¶Ü°Ø¥Î¶q¡C
¡]»ôªi Ķ ¤ý²»·ç®Õ¡^
The objective of our study was to see if incisional and intraperitoneal bupivacaine with epinephrine produces analgesia after total abdominal hysterectomy. Forty-six ASA physical status I and II patients received a standardized anesthetic, patient-controlled analgesia (PCA) morphine, and rectal paracetamol 1 g every 6 h. Patients were randomized to receive 50 mL of bupivacaine 0.25% with epinephrine 5 µg/mL or 50 mL of normal saline. Thirty milliliters and 20 mL of treatment solution were administered into the peritoneum and incision, respectively, before wound closure. Seventeen and 16 patients in the Placebo and Bupivacaine groups, respectively, completed the study. The reasons for withdrawal were PCA malfunction, PCA discontinued too early, nausea, chest infection, intraabdominal drain insertion, and protocol violation. There were no significant differences between the Bupivacaine and Placebo groups in age, height, weight, or duration of surgery. Pain on movement was significantly more intense in the Placebo group than in the Bupivacaine group on awakening. Morphine consumption (interquartile range) over 24 h was 62 mg (53-85 mg) in the Placebo group compared with 44 mg (33-56 mg) in the Bupivacaine group (P < 0.01). This significant difference was attributable to the larger morphine consumption in the Placebo group in the first 4 postoperative h. We conclude that a combination of intraperitoneal and incisional bupivacaine with epinephrine provides significant morphine-sparing analgesia for 4 h after total abdominal hysterectomy.
³æ·¥©MÂù·¥ÉaºÞ¤º¹q·¥¥Î¤_¹q¨ë¿E³qÉa
Electroventilation with Monopolar and Bipolar Intratracheal Electrodes
Zachary W. Sopcak, MSBME, L. A. Geddes, PhD, Kirk S. Foster, BSEE, William E. Schoenlein, BS, and Joe D. Bourland, PhD
Purdue University Department of Biomedical Engineering, West Lafayette, Indiana
Anesth & Analg July 2002 95:189-191
¥Øªº ¹q¨ë¿E³qÉa¡]electroventilation¡^¬O¤@Ïú³q¹Lºë¤ß©ñ¸m¤_Åéªí©ÎÅ餺ªº¹q·¥µ¹¤©§lÉa¦Ù¹q¨ë¿E¥H²£¥Í§lÉa°Ê§@ªº§Þ³N¡C¥»¬ã¨s¤ÀªR¨Ï¥Î³æ·¥©MÂù·¥ÉaºÞ¤º¹q·¥¶i¦æ¹q¨ë¿E³qÉaªº¦³®Ä©Ê¡C¤èªk ¿ï¾Ü7¥uª¯¬°¹êÅç¹ï¶H¡C¸m©ñ³æ·¥©MÂù·¥ÉaºÞ¤º¹q·¥¶i¦æ¹q¨ë¿E³qÉa¡A°O¿ý¦Ûµoªº¼éÉa¶q©M¨ë¿E©Ò»Ý¹q¬y¤Î§lÉa¶q¡Cµ²ªG ¨Ï¥ÎÂù·¥¹q·¥¥i¥H¨Ï©Ò¦³7¥uª¯ªº§lÉa¶q§¡¤j¤_¦Ûµoªº¼éÉa¶q¡A¦ý¬O¨Ï¥Î³æ·¥¹q·¥¶È¯à¨Ï¨ä¤¤3¥u§lÉa¶q¼W¤j¡C¨Ï¥ÎÉaºÞ¤º¹q·¥²£¥Í³æ¦¸¼éÉa¶q©Ò»Ý¹q¬y¤ñÅéªí¹q·¥¤p¡A¥B¹q·¥¸m©ñ¤ñ¨Ï¥Î¹¹D¤º¹q·¥¤è«K¡C¹êÅçµ²ªGÅã¥ÜÂù·¥¹q·¥¥i¥H³Q¥Î¨Ó¶i¦æ¹q¨ë¿E³qÉa¡Cµ²½× ¥»¬ã¨s»¡©ú¹q¨ë¿E³qÉa¥i¥H¨Ï¥ÎÉaºÞ¤º¹q·¥¡A©Ò»Ý¨ë¿E¹q¬y¤ñ¨Ï¥ÎÅéªí¹q·¥´î¤p¡CÉaºÞ¤º¹q·¥³qÉa¦³¨âÏú¤è¦¡¡G¤@Ïú¬O³æ·¥¦¡¡A¨äªð¦^¹q·¥¦ì¤_Åéªí¡F¥t¤@Ïú¬OÂù·¥¦¡¡A¨äªð¦^¹q·¥¦ì¤_ÉaºÞ¤º¡C
¡]¸¯Éoª÷Ķ Éܤߨ}®Õ¡^
Electroventilation is the technique of producing inspiration with stimuli applied to inspiratory muscles by using strategically placed electrodes on or within the body. We conducted studies using the dog to determine the efficacy of monopolar and bipolar intratracheal electrodes for electroventilation. Bipolar electrodes were able to produce an inspired volume greater than a spontaneous tidal volume in all seven dogs, but monopolar electrodes were able to in only three of seven dogs. The intratracheal electrode has the advantage over body-surface electrodes that less current is required to produce a single tidal volume, and it has the advantage over intraesophageal electrodes that anatomical placement of the electrode is simplified. These experiments demonstrated that a bipolar electrode can be used for electroventilation.
¡@
«Ø¥ßÀ£¤O-±±¨î¼Ò¦¡®ÉÉaºÞ¾ÉºÞ³vº¥ªý¶ë®É¼éÉa¶qÅܤƪº¼Ò«¬
Modeling the Effect of Progressive Endotracheal Tube Occlusion on Tidal Volume in Pressure-Control Mode
Avery
Tung, MD*, and Sherwin E. Morgan, RRT![]()
Departments of
*Anesthesia and Critical Care and
Respiratory Therapy, University of Chicago, Chicago,
Illinois
Anesth & Analg July 2002 95:192-197
¥Øªº ¦]Éa¹D¤Àªcª«¥i¦bÉaºÞ¾ÉºÞ¡]ETT¡^¤ºªº¨I¿n¡Aªø´Á¨Ï¥ÎÉaºÞ´¡ºÞªº¥Dnªº¦MÀI¬OÉa¹D³vº¥ªý¶ë¡C¦b¨Ï¥Î®e¿n-±±¨îªº©I§lÉó®É¡AºÊ´ú®pÈ©M¥¥x´ÁªºÉa¹DÀ£®t¦³§U¤_¬dıETTªý¶ëªº§Î¦¨¡CµM¦Ó¦bÀ£¤O-±±¨îªº©I§lÉó¡A§lÉa®ÉªºÉa¹DÀ£¬O¹w¥ý³]©wªº¡A¦]¦¹¤£¯à§@¬°³øÄµ«ü¼Ð¡A¨ú¦Ó¥N¤§¬O¥H¼éÉa¶qªºÅܤÆÀ°§U§PÂ_ETTªº°ô¶ë¡C¥»¤åªö¥Î¼Æ¾Ç¤è¦¡¼ÒÀÀ¦b³vº¥¼W¥[Éa¹Dªý¤O®ÉÀ£¤O-±±¨î¼Ò¦¡©I§lÉ󪺤ÏÀ³¡A¶i¦ÓÅçÃҺʴú¼éÉa¶q¬O§_¯à¦³®Äªºµo²{¶i®i¤¤ªºÉa¹Dªý¶ë¡C¤èªk ¬°¤FÚÌÃÒ§@ªÌªº¼Ò«¬¡A§@ªÌªö¥Î¹êÅçªÍ©M¤º®|¥Ñ9.0mm¨ì3.5mmªºÉaºÞ¾ÉºÞ¡]¼ÒÀÀ³vº¥ªý¶ëªºÉa¹D¡^ÀË´ú¦èªù¤l 300«¬©MPuritan-Bennett 7200«¬©I§lÉó¡Cµ²ªG §@ªÌµo²{·í¨Ï¥ÎÀ£¤O-±±¨î¼Ò¦¡®É¡Aª½¨ìÉa¹D¤Lªñ§¹¥þªý¶ë¡A¼éÉa¶q¤~°§C¡Cµ²½× §@ªÌ»{¬°ªø´Á¨Ï¥ÎÀ£¤O-±±¨î©I§l¼Ò¦¡¡A·|¾ÉPETTµo¥Í©úÅãªý¶ë¦Ó¤£¯àµoı¡A¦³µo¥ÍÉaºÞ§¹¥þªý¶ëªº¦MÀI¡A¦P®É¥Î¦¹³qÉa¼Ò¦¡¨Ï±wªÌ³ò³N´Áªº³B²zÅÜÎ`Âø¡C
¡]»¯³·½¬Ä¶ Éܤߨ}®Õ¡^
A recognized hazard of prolonged endotracheal intubation is progressive airway occlusion resulting from deposition of secretions on the inner surface of the endotracheal tube (ETT). When volume-controlled ventilation is used, progressive ETT occlusion may be detected by monitoring the difference between peak and plateau airway pressures. In pressure-controlled modes, however, inspiratory airway pressures are preset and thus cannot act as a warning indicator. Instead, changes in delivered tidal volumes may aid the diagnosis of ETT occlusion. To determine whether tidal volume monitoring effectively de-tects progressive ETT occlusion, we mathematically modeled the response of a ventilator operating in pressure-controlled mode to increasing airway resistance. To corroborate our model, we then bench-tested the Siemens 300 and Puritan-Bennett 7200 ventilators by using a test lung and a series of ETTs ranging in size from 9.0 to 3.5 mm inner diameter to simulate progressive occlusion. We found that when pressure-controlled mode was used, progressive ETT occlusion did not reduce delivered tidal volumes until occlusion was nearly complete. We conclude that prolonged use of pressure-controlled mode may allow significant ETT obstruction to build up undetected, risking complete ETT occlusion and complicating the perioperative care of patients ventilated with this mode.
¡@
µw½¤¥~À³¥Î¥¬¤ñ¥d¦]©Mùûê¥d¦]¤À®YÂíµhªº¬Û¹ï¹B°Ê¯«¸gªýº¢®Ä¯à
The Relative Motor Blocking Potencies of Epidural Bupivacaine and Ropivacaine in Labor
Héctor J. Lacassie, MD*, Malachy O. Columb, FRCA, Héctor P. Lacassie, MD, and Rodrigo A. Lantadilla, MD*
*Anesthesiology Department, Pontificia Universidad Católica de Chile; and Anesthesiology Service, Clínica Alemana, Santiago, Chile; and South Manchester University Hospital, Withington, United Kingdom
Anesth & Analg July 20002 95:204-208.
¥Øªº ³Ì¤p§½³ÂÃÄ¿@«×(MLAC)¤w¥Î¤_µû»ùµw½¤¥~À³¥Î¥¬¤ñ¥d¦]©Mùûê¥d¦]ªºÂíµh®Ä¯à¡C¥Ø«e©|µL¦¹ÃþÃĪ«¹B°Ê¯«¸gªýº¢®Ä¯àªº³ø¹D¡C¥»¬ã¨s¥DnÆ[¹î¨âºØÃĪ«¦bMLAC®Éªº¹B°Ê¯«¸gªýº¢®Ä¯à©M¨âºØÃĪ«ªº¬Û¹ï®Ä¯à¤ñ¡C¤èªk 60¨ÒASA I-II ¯Åªº²£°ü³QÀH¾÷¤À¬°¨â²Õ¡M¦b²Ä¤@²£µ{¤À§Oµ¹¤©¨â²Õ²£°ü¥¬¤ñ¥d¦]©Îùûê¥d¦]20ml³æ¦¸¾¯¶q¡C¨C¤@²Õ²Ä¤@Ó²£°ü©Òµ¹ÃĪ«ªº¿@«×¬°0.35%¡M¨ä¾l²£°üªºÃĪ«¿@«×¦b0.35%ªº°ò¦¤W¨Ì¦¸»¼¼W©Î»¼´î¤@Ó¹êÅç¶¡¹j¾¯¶q0.025%¡C¦b30¤ÀÄÁ¤ºBromageµû¤À<4«h»{¬°¬O¦³®Äªº¹B°Ê¯«¸gªýº¢¡Cµ²ªG À³¥ÎDixon©MMassey¤ÀªR²£°üÃĪ«¿@«×ªº¤W-¤U¶¶§Ç¡M¨Ã¥Î·§²v¦^Âk¶q¤Æ¹B°Ê¯«¸gªýº¢ªº³Ì¤p§½³ÂÃÄ¿@«×¡C¨â¤è±§¡¤_P<0.05®É¦³©úÅã®t²§¡Cµ²ªG ¥¬¤ñ¥d¦]ªº¹B°Ê¯«¸gªýº¢ªº³Ì¤p§½³ÂÃÄ¿@«×¬°0.326%(95%¥i¾a°Ï¶¡[CI]¡M0.285-0.367)¡Mùûê¥d¦]¬°0.497%(95%CI¡M0.431-0.563) (p=0.0008)¡C¥¬¤ñ¥d¦]/ùûê¥d¦]®Ä¯à¤ñ¬°0.66 (95%CI¡M0.52-0.82)¡Cµ²½× ¥»¤åº¦¸µû¦ô¥¬¤ñ¥d¦]©Mùûê¥d¦]¹B°Ê¯«¸gªýº¢®Ä¯àMLAC¡Mùûê¥d¦]ªº¹B°Ê¯«¸gªýº¢®Ä¯à¸û§C¡M¶È¬°¥¬¤ñ¥d¦]ªº66%¡C
¡]»ôªi Ķ ¤ý²»·ç®Õ¡^
Minimal local analgesic concentrations (MLAC) have been used to determine the epidural analgesic potencies of bupivacaine and ropivacaine. There are no reports of the motor blocking potencies of these drugs. We sought to determine the motor block MLAC of both drugs and their relative potency ratio. Sixty ASA physical status I and II parturients were randomized to one of two groups, during the first stage of labor. Each received a 20-mL bolus of epidural bupivacaine or ropivacaine. The first woman in each group received 0.35%. Up-down sequential allocation was used to determine subsequent concentrations at a testing interval of 0.025%. Effective motor block was defined as a Bromage score <4 within 30 min. The up-down sequences were analyzed by using the Dixon and Massey method and probit regression to quantify the motor block minimal local analgesic concentration. Two-sided P < 0.05 defined significance. The motor block minimal local analgesic concentration for bupivacaine was 0.326% (95% confidence interval [CI], 0.285-0.367) and for ropivacaine was 0.497% (95% CI, 0.431-0.563) (P = 0.0008). The ropivacaine/bupivacaine potency ratio was 0.66 (95% CI, 0.52-0.82). This is the first MLAC study to estimate the motor blocking potencies of bupivacaine and ropivacaine. Ropivacaine was significantly less potent for motor block, at 66% that of bupivacaine.
¡@
§¤°©¯«¸gªýº¢«e¸ôªkªº·s¼Ð§Ó¡G¼v¹³¾Ç©MÁ{§É¬ã¨s
New Landmarks for the Anterior Approach to the Sciatic Nerve Block: Imaging and Clinical Study
Alain
C. Van Elstraete, MD*, Claude Poey, MD
,
Thierry Lebrun, MD*, and Frédéric Pastureau, MD*
Departments
of *Anesthesiology and
Radiology,
Saint-Paul Medical Center, Fort de France, Martinique, France
Anesth & Analg July 2002 95:214-218
¥Øªº µûɲ¸¡ªÑ·¾Á·½K©MªÑ°Ê¯ß§@¬°«e¸ô§¤°©¯«¸gªýº¢¸Ñå¼Ð§Óªº¥i¾a©Ê¦}ÚÌ©w¦¹¸ô®|®É»Lªº²z·Q¦ì¸m¡C¤èªk Á{§É¬ã¨s«e¥ý¶i¦æ¤@¶µ¼v¹³¾Ç¬ã¨s¡A¥H¨âÏú©w¦ì¤èªk¹ï20¨Ò¦æ¸}½ï©M¨¬³¡¤â³Nªº¯f¤H¦æ§¤°©¯«¸gªýº¢¡G¤@¬°»L¤¤¶¡¦ì¡A¤@¬°»L¥~±Û¦ì¡A¯f¤H§¡¬°¥õª×¦ì¡C¨Ï¥Î¤@¤ä³s±µ¯«¸g¨ë¿E¾¹ªº22¸¹150mmªø±×¨¤°w±qÖø¡ªÑ·¾Á·½K2.5cm»·¡A¶ZªÑ°Ê¯ß2.5cm»·³B¦V¦Z°¼¤è¦VÉO««ª½±¦¨10~15«×¨¤¤è¦V¶i°w¡Cµ²ªG »L¦b¤¤¶¡¦ì®É¡A©Ò¦³¯f¤Hªº§¤°©¯«¸gªýº¢ÂI©w¦ì¤_10.6¡Ó1.8cm²`«×¡A¦Ó»L¥~±Û¦ì®É«h¬O10.4¡Ó1.5cm(µLÅãµÛ®t§O)¡C»L¤¤¶¡¦ì©M¥~±Û¦ì®É¡AÚÌ©w¸Ñå¼Ð§Óªº®É¶¡¤À§O¬O28¡Ó15s©M26¡Ó14s(µLÅãµÛ®t§O)¡CÚÌ©w§¤°©¯«¸gªýº¢ªº®É¶¡¤À§O¬°79¡Ó53s©M46¡Ó25s (p<0.006)¡C§ÚÌÚÌ©w¸¡ªÑ·¾Á·½K©MªÑ°Ê¯ß¬O«e¸ô§¤°©¯«¸gªýº¢ªº¥i¾a¤Î¦³®Äªº¸Ñå¼Ð§Ó¡A²z·QªºÅé¦ì¬O»L¥~±Û¦ì¡Cµ²½× ¥H¸¡ªÑ·¾Á·½K©MªÑ°Ê¯ß§@¬°¶i¦æ§¤°©¯«¸gªýº¢ªº¼Ð§Ó¬O¤@¶µÂ²«K©M¥i¾aªº§Þ³N¡C
¡]µJ§ÓµØÄ¶ Éܤߨ}®Õ¡^
In this study, we assessed the reliability of the inguinal crease and femoral artery as anatomic landmarks for the anterior approach to the sciatic nerve and determined the optimal position of the leg during this approach. An imaging study was conducted before the clinical study. The sciatic nerve was located twice in 20 patients undergoing ankle or foot surgery, once with the leg in the neutral position and once with the leg in the externally rotated position. The patient was lying supine. A 22-gauge, 150-mm insulated b-beveled needle connected to a nerve stimulator was inserted 2.5 cm distal to the inguinal crease and 2.5 cm medial to the femoral artery and was directed posteriorly and laterally with a 10¡ã¨C15¡ã angle relative to the vertical plane. The sciatic nerve was located in all patients at a depth of 10.6 ¡Ó 1.8 cm when the leg was in the neutral position and 10.4 ¡Ó 1.5 cm when the leg was in the externally rotated position (not significant). In the neutral position and in the externally rotated position, the time needed to identify anatomic landmarks was 28 ¡Ó 15 s and 26 ¡Ó 14 s, respectively (not significant), and the time needed to locate the sciatic nerve was 79 ¡Ó 53 s and 46 ¡Ó 25 s (P < 0.006), respectively. We conclude that the inguinal crease and femoral artery are reliable and effective anatomic landmarks for the anterior approach to the sciatic nerve and that the optimal position of the leg is the externally rotated position.
¡@
°§C§l¤J¯º®ð¿@«×«á¹ïÂùµÄºÞ¤ä®ðºÞ®MÅn¨³³t©ñ®ðªº¬ã¨s
Rapid Deflation of the Bronchial Cuff of the Double-Lumen Tube After Decreasing the Concentration of Inspired Nitrous Oxide
Fujio Karasawa, MD, Akira Takita, MD, Isao Takamatsu, MD, Tomohisa Mori, MD, Takashi Oshima, MD, and Yasushi Kawatani, MD
Department of Anesthesiology, National Defense Medical College, Saitama, Japan
Anesth & Analg July 2002 95:238-242.
¥Øªº ³Â¾K¤¤§l¤J¯º®ð(N2O)¿@«×´î¤p«á®ðºÞ¤º®MÅn¥iµo¥Í©ñ®ð²{¶H¡M¥»¤å¬ã¨sÂùµÄºÞ(DLT)®MÅnªº©ñ®ð²{¶H¡C¤èªk ÀH¾÷¬D¿ï24¨Ò¦æ¯Ý¥~¬ì¤â³Nªº¯f¤H¡M¨ÃÀH¾÷¤À¬°¤T²Õ¡M±Ä¥ÎMallinckrodtÂùµÄºÞ(Athlone, Ireland)¡M¦bÂùµÄºÞªº®ðºÞ®MÅn©M¥ª¤ä®ðºÞ®MÅn¤º¤À§O¥Rº¡ªÅ®ð¡N40%N2O©M67%N2O(¤À§O©R¦W¬°ªÅ®ð²Õ¡NN40²Õ©MN67²Õ)¡C40¤ÀÄÁ«á¡M±NN40²Õ³¡¥÷¯f¤H®MÅn¤ºªºN2O§ï¬°O2(©R¦W¬°N40-c²Õ)¡C´ú©w®MÅn¤º®ðÅé®e¿n¡NN2O¿@«×©M®MÅn¶¶À³©Ê¡Cµ²ªGªÅ®ð²Õ¯f¤Hªº®ðºÞ©M¤ä®ðºÞ®MÅnªºÀ£¤O©úÅã¼W¤j¡M¦ÓN67²Õ´î¤p¡CN40²ÕµL©úÅã§ïÅÜ¡M¦ýN40-c²Õ¯f¤H¦b¯º®ð³Â¾Kµ²§ô«á¡M®ðºÞ©M¤ä®ðºÞ®MÅnªºÀ£¤O§¡°§C¡C¤ä®ðºÞ®MÅnÀ£¤O´î¤p¤@¥b©Ò»Ý®É¶¡(12.0+_5.5min)nµu¤_®ðºÞ®MÅnÀ£¤O´î¤p¤@¥b©Ò»Ý®É¶¡(31.2+_11.0min , P<0.01)¡CN40-c²Õ¯f¤Hªº®ðºÞ®MÅn©M¤ä®ðºÞ®MÅnªº®e¿nÅܤƵLÅãµÛ®t²§¡M¦ý®ðºÞ®MÅnªº¶¶À³©Ê©úÅã°ª¤_¤ä®ðºÞ®MÅn¡Cµ²½× ¦bÀ³¥Î67%N2O¶i¦æ³Â¾K®É¡M¦p±Ä¥Î40%N2O¥R¶ñDLT®MÅn¥iéw®MÅnÀ£¤O¡M¦b²×¤îÀ³¥ÎN2O«á¡M¦]¬°¤ä®ðºÞ®MÅnªº¶¶À³©Ê¤p¡M¦]¦¹¤ñ®ðºÞ®MÅn©ñ®ð§ó¥[§Ö¡C
¡]Êã¬öµØ Ķ ¤ý²»·ç®Õ¡^
Deflationary phenomena of the endotracheal tube cuff may occur after inspired nitrous oxide (N2O) concentrations are reduced, but deflationary phenomena of the double-lumen tube (DLT) cuff have not been investigated. In this study, tracheal and bronchial cuffs of left-sided Mallinckrodt (Athlone, Ireland) DLTs were inflated with air, 40% N2O, or 67% N2O (Air, N40, or N67 groups, respectively) in 24 patients undergoing thoracic surgery; 40 min later, O2 was substituted for N2O in some of the patients in the N40 group (N40-c group). Intracuff gas volumes, N2O concentrations, and cuff compliance were also measured. Both tracheal and bronchial cuff pressures significantly increased in the Air group but decreased in the N67 group. Neither pressure significantly changed in the N40 group, but both decreased in the N40-c group after terminating N2O anesthesia; the time required for bronchial cuff pressures to decrease by half (12.0 ¡Ó 5.5 min) was less than that for tracheal cuff pressures (31.2 ¡Ó 11.0 min, P < 0.01). The volume change in the N40-c group was not significantly different between the tracheal and bronchial cuffs, but tracheal cuff compliance was significantly higher than bronchial compliance. Therefore, filling DLT cuffs with 40% N2O stabilizes cuff pressure during anesthesia with 67% N2O, but bronchial cuffs deflate more quickly than tracheal cuffs after cessation of N2O administration through smaller compliance.
N2O³Â¾K®É®ðºÞ®MÅn«½Æ©ñ®ð¥Héw®MÅn¤ºÀ£¤O
Repeated Deflation of a Gas-Barrier Cuff to Stabilize Cuff Pressure During Nitrous Oxide Anesthesia
Fujio Karasawa, MD, Nobuhiro Matsuoka, MD, Mitsuyoshi Kodama, MD, Tomohiro Okuda, MD, Tomohisa Mori, MD, and Yasushi Kawatani, MD
Department of Anesthesiology, National Defense Medical College, Tokorozawa, Saitama, Japan
Anesth & Analg July 2002 95:243-248
¥Øªº µûɲN2O³Â¾K¤¤®ðºÞ®MÅn«½Æ©ñ®ð®É¸Ë¦³N2Oªý¾×¾¹ªº®ðºÞ¾ÉºÞ®MÅn¬O§_¸û¼Ð·Çªº®ðºÞ¾ÉºÞ®MÅn¯à§ó¦³®Ä¦aéw®MÅn¤ºÀ£¤O¡C¤èªk ¤À§O´ú¶q67%N2O³Â¾K¡]¨C²Õ8¤H¡^¤¤¥Rº¡®ðÅ骺¼Ð·Ç«¬®ðºÞ®MÅn©M¸Ë¦³N2Oªý¾×¸Ë¸mªº³n¶ë§Î®ðºÞ¤º®MÅn¡]PSSC¡^À£¤O¡C°_ªìªº3-4¤p®É¤º¡M®ðÅn¨C¹j30©Î60¤ÀÄÁ©ñ®ð¤@¦¸¡Cµ²ªG §lÉa3¤p®É«á¡M¨â²Õ¤¤¥b¼Æ¥H¤W¯f¤Hªº®ðºÞ®MÅnÀ£¤O¶W¹L22mmHg¡C¦Ó¨â²Õ¤¤§l®ð4¤p®Éªº®ðºÞ®MÅn¦b©ñ®ð¶¡¹j´Áªº³Ì¤jÀ£¤O¤w¸g°§C¡]p<0.01¡^¡M®ðºÞ®MÅn¤ºN2O¿@«×¼W°ª¡]p<0.001¡^¡C«½Æ©ñ®ð4¤p®É«á¡M¨â²Õ¯f¤H¦b±µ¤U¨Óªº3¤p®É¤¤®ðºÞ®MÅnÀ£¤O¦A¤]¤£¶W¹L22mmHg¡M®MÅn¤ºN2O¿@«×¤]µL©úÅãÅܤơC¦]¦¹¡MN2O³Â¾K®É4¤p®É¤º«½Æ©ñ®ð¥i¦³®Äéw¨â²Õ®ðÅnÀ£¤O©M¥¿Å®ðÅn¤ºN2O¿@«×¡C¦ý¬OPSSC¨S¦³´î¤Ö©ñ®ð®É¶¡¥héwÀ£¤O¡Cµ²½× N2O³Â¾K¤¤®ðºÞ®MÅn±q2¤p®É¥R®ð¨ì4¤p®É®É¡M¸Ë¦³N2Oªý¾×¾¹ªº³n¶ë®ðÅn¤¤N2O¿@«×©MÀ£¤O³vº¥Ã©w¡M¥B¦]¬°»Ýn©ñ®ðªº¦¸¼Æ¸û¤Ö¡M³n¶ë§Î®ðºÞ®MÅn±N¤ñ¼Ð·Ç®ðºÞ®MÅn§ó¤è«KÀ³¥Î¤_Á{§É¡C
¡]µJ§ÓµØÄ¶ ²ø¤ß¨}®Õ¡^
Although a nitrous oxide (N2O) gas-barrier cuff effectively limits the increase of cuff pressure during N2O anesthesia, there are few data assessing whether an N2O gas-barrier cuff is more beneficial for stabilizing intracuff pressure than standard endotracheal tubes when cuffs are repeatedly deflated to stabilize pressure during N2O anesthesia. In the present study, the pressure of air-filled standard-type cuffs (Trachelon; Terumo, Tokyo, Japan) and N2O gas-barrier type endotracheal tube cuffs (Profile Soft-Seal Cuff [PSSC]; Sims Portex, Kent, UK) was measured during 67% N2O anesthesia (n = 8 in each), during which the cuffs were repeatedly deflated every 30 min (Trachelon) or 60 min (PSSC) for the first 3 or 4 h. After aspirating the cuffs for 3 h, the cuff pressure exceeded 22 mm Hg in more than half of the patients in both groups. However, aspiration of the cuffs for 4 h decreased the maximal cuff pressure between deflation intervals in both groups (P < 0.01 for each), and increased the intracuff N2O concentration (P < 0.0001 for each). After deflating the cuffs over 4 h, the cuff pressure in both groups never exceeded 22 mm Hg during the subsequent 3 h, and intracuff N2O concentrations did not significantly change. Therefore, deflation of cuffs for 4 h during N2O anesthesia sufficiently stabilized cuff pressure and equilibrated the intracuff N2O concentrations in both groups. The use of the PSSC endotracheal tube might be more practical because of the smaller number of cuff deflations required, but the PSSC does not reduce the duration of cuff deflations to stabilize the pressure.
¡@